Home » News » Clinical Intelligence » Clinical research in the cloud, with help from Microsoft

Clinical research in the cloud, with help from Microsoft

Monday, October 30, 2017

Clinical research technology is expanding, and there is now infrastructure to back it. Last week, Parexel, a global clinical research organization, announced a new partnership with Microsoft to develop innovative cloud-based services for their clients. The collaboration will bring Parexel’s current tech offerings to the Microsoft Azure cloud platform and catalyze new developments aimed at enhancing participant engagement in clinical trials, and streamlining drug development.

Circuit Clinical, ePatientFinder partner

Circuit Clinical and ePatientFinder are partnering to address a longstanding challenge in clinical trial research: expanding the pool of qualified patients. The agreement between the two companies will create one of the largest clinical research site networks in the U.S., serving more than 200 sites. The partnership relies on the most personal of relationships, according to the CEOs of both companies—that between a patient and their doctor. “We’re going to tap into a new pool of patients who have never had the opportunity to participate [in a clinical trial] … and this partnership will create one of the biggest site networks,” Tom Dorsett, CEO at ePatientFinder, told CenterWatch. “Our premise is patients are more comfortable working with their own doctor.”


To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!